News
Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced new data from the Phase I/II GOBLET clinical trial in a poster presentation at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback